Vectors Research Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Vectors Research Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-24	Closed	-$5K	–	521
2021 Q1	$5K	Hold	24	–	–	﹤0.01%	393
2020 Q4	$3K	Hold	24	–	–	﹤0.01%	412
2020 Q3	$2K	Hold	24	–	–	﹤0.01%	400
2020 Q2	$3K	Hold	24	–	–	﹤0.01%	385
2020 Q1	$2K	Hold	24	–	–	﹤0.01%	444
2019 Q4	$3K	Hold	24	–	–	﹤0.01%	482
2019 Q3	$3K	Hold	24	–	–	﹤0.01%	421
2019 Q2	$4K	Sell	24 -27	-53%	-$4.67K	﹤0.01%	359
2019 Q1	$9K	Buy	+51	New	+$7.59K	0.01%	291

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Vectors Research Management's GWPH Position: Q2 2021 in Review

Vectors Research Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 24 shares — an estimated $5K sold.

Vectors Research Management first reported a position in GWPH in Q1 2019 and held it in 9 quarters. The position peaked at $9K in Q1 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Vectors Research Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Vectors Research Management sold 24 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $5K.
Vectors Research Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 9 quarters.
Vectors Research Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $9K in Q1 2019.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Vectors Research Management's 13F filing for Q2 2021, filed 9 Aug 2021.